Home › NDC Lookup › Ingredients › Hexylresorcinol › 72854-0261-20
Mucinex Instasoothe Sore Throat plus Soothing Comfort Hexylresorcinol 2.4 mg Lozenge, 20-count — NDC 72854-0261-20 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Mucinex Instasoothe Sore Throat plus Soothing Comfort Hexylresorcinol 2.4 mg Lozenge, 20-count — NDC 72854-261-20 (Billing 72854-0261-20)

by Reckitt Benckiser LLC · 20 POUCH in 1 BAG / 1 LOZENGE in 1 POUCH

This is a package of 20 lozenges of Mucinex Instasoothe Sore Throat plus Soothing Comfort Hexylresorcinol 2.4 mg Lozenge from Reckitt Benckiser LLC, marketed since Jul 2021 and currently FDA-listed; retail pharmacies pay about $0.1227 per lozenge (NADAC). It is the main listing for this product, which comes in 2 package sizes.

NDC 72854-0261-20
🏷️ FDA NDC (as labeled) 72854-261-20 billing pads the product segment with a zero
This package
Contains20-count Cost per ea$0.1227 NADAC Per package$2.45 / 20 lozenge Pack sizes2 compare ↓
Main listing for product 72854-261 · Also comes in: 40 lozenges 72854-261-40
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Sep 17, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 72854-261-20
Product NDC 72854-261
11-digit billing NDC 72854026120
NCPDP billing unit EA — each (per item)
RxCUI 247463
UNII R9QTB5E82N
UPC 0363824215709
Application # M022
SPL Set ID 91cd2964-5d83-4e40-bc18-e3e5462f454a
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2021-07-01
Route ORAL
Dosage form LOZENGE
Substance HEXYLRESORCINOL

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GCN Seq No 021874
GCN 41041
HICL code 000513
Ingredient (HICL) Hexylresorcinol
HIC1 code B
Therapeutic class — broad (HIC1) Respiratory System
HIC2 code B3
Therapeutic class — intermediate (HIC2) Drugs Affecting Primarily The Trachea And Bronchi
HIC3 code B3K
Therapeutic class — specific (HIC3) Cough And/Or Cold Preparations
AHFS code 52:16.00.00
AHFS class Local Anesthetics (Eent)
FDB label name MUCINEX INSTASOOTHE CMFT 2.4MG
FDB brand name Mucinex Instasoothe Comfort
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 021874
  • GCN: 41041
  • HICL (First Databank): 000513
  • AHFS class code: 52:16.00.00
  • RxCUI (RxNorm): 247463
Why two NDCs? The FDA registers this code as 72854-261-20 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 72854-0261-20. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Antiseptics class.

Drug family (ATC) Antiseptics
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name MUCINEX INSTASOOTHE CMFT 2.4MG Ingredient Hexylresorcinol
🧪 What is this product?

Mucinex InstaSoothe Sore Throat Plus is an over-the-counter lozenge taken by mouth. It contains hexylresorcinol, an ingredient typically used in oral lozenges to help numb and soothe sore throat discomfort. This product is marketed under the FDA's OTC monograph rules for throat lozenges rather than as an individually approved drug application.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.123 $2.45 / 20 lozenge
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per ea) — tap or hover for the price & month
Sep 2022 Mar 2023 Feb 2024 $0.123 $0.120
▲ Up 2% over the last 3 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Per unit Per pack Marketing startMarketing endStatus
72854-0261-20 You're viewing this Main listing 20 POUCH in 1 BAG / 1 LOZENGE in 1 POUCH $0.1227 / ea $2.45 2021-07-01 — Active
72854-0261-40 72854-261-40 40 POUCH in 1 BAG / 1 LOZENGE in 1 POUCH $0.1227 / ea $4.91 2021-07-01 — Active

This pack has the lowest per-ea cost of the 2 priced pack sizes ($0.1227 NADAC).

Pack size FAQ

What quantity is in this package?
This is a 20-count package — 20 pouch in 1 bag / 1 lozenge in 1 pouch.
How does this package differ from NDC 72854-0261-40?
Both are Mucinex Instasoothe Sore Throat plus Soothing Comfort Hexylresorcinol 2.4 mg Lozenge — the drug itself is identical. This page's package is the 20-count one, while NDC 72854-0261-40 is the 40 lozenges package.
What NDC number is used to bill for this package of Mucinex Instasoothe Sore Throat plus Soothing Comfort Hexylresorcinol 2.4 mg Lozenge?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Mucinex Instasoothe Sore Throat Plus Soothing Comfort 2.4 mgthis 72854-0261-20 Reckitt 20 lozenges $0.123 — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2021
On the market since
Jul 2021
📍
2026
Currently FDA-listed
5 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color yellow
ShapeRound
ImprintS
Size18 mm
ScoringNot scored
FlavorHoney
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 9G5L16BK6N
    A thick, sweet liquid made from corn starch. It acts as a sweetener, thickener, and binder in medicines, helping create the right texture and taste while holding ingredients together.
  • UNII 35SW5USQ3G
    A synthetic yellow dye used to color medicines. It helps make tablets, capsules, and liquids visually distinct so patients can easily identify their medication.
  • UNII H77VEI93A8
    A synthetic yellow dye used to color medications. It helps identify the drug and make it visually distinctive, with no effect on how the medicine works.
  • UNII Y9H1V576FH
    Honey is a natural sweetener made by bees from flower nectar. In medicines, it adds sweetness to improve taste and may help soothe throat irritation in lozenges or syrups.
  • UNII 6DC9Q167V3
    Propylene glycol is a clear liquid derived from petroleum or vegetable sources. It acts as a solvent, humectant, and preservative in medicines, helping dissolve active ingredients and maintain product stability.
  • UNII C151H8M554
    A natural sugar derived from sugar cane or sugar beets. It's used as a sweetener, filler, and binder to improve taste, add bulk, and help hold tablet or capsule ingredients together.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.

7 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statescorn syrup, D&C yellow no. 10, FD&C yellow no. 6, flavor, honey, propylene glycol, purified water, sucrose

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerReckitt Benckiser LLC
FDA applicationM022 (OTC MONOGRAPH DRUG)
Labeler code72854
First marketedJul 2021
Product typeHuman Otc Drug
Portfolio174 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 🤰 If Pregnant or Breast-Feeding 📄 Keep Out of Reach of Children 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 16 words ▾

Uses temporarily relieves occasional minor irritation and pain associated with: sore throat sore mouth canker sores

⏱️ Dosage and Administration 44 words ▾

Directions adults and children 6 years of age and older: allow one lozenge to dissolve slowly in the mouth; may be repeated every 2 hours as needed or as directed by a doctor or dentist. children under 6 years of age: do not use

⚠️ Warnings 112 words ▾

Warnings Sore throat warning : If sore throat is severe, persists for more than 2 days, is accompanied or followed by fever, headache, rash, swelling, nausea, or vomiting, consult a doctor promptly. Do not use in children under 6 years of age When using this product do not exceed recommended dosage Stop use and ask a doctor or dentist if sore mouth symptoms do not improve in 7 days irritation, pain, or redness persists or worsens swelling, rash, or fever develops If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

📦 Storage and Handling 22 words ▾

Other information store at 20-25°C (68-77°F) protect contents from humidity Keep lozenge in outer pack until use. Reseal outer pack after use.

🧪 Active Ingredient 8 words ▾

Active ingredient (in each lozenge) Hexylresorcinol 2.4 mg

🧪 Inactive Ingredients 19 words ▾

Inactive ingredients corn syrup, D&C yellow no. 10, FD&C yellow no. 6, flavor, honey, propylene glycol, purified water, sucrose

🎯 Purpose 4 words ▾

Purpose Oral pain reliever

📄 Do Not Use 10 words ▾

Do not use in children under 6 years of age

📄 When Using This Product 9 words ▾

When using this product do not exceed recommended dosage

📄 Stop Use and Ask a Doctor If 30 words ▾

Stop use and ask a doctor or dentist if sore mouth symptoms do not improve in 7 days irritation, pain, or redness persists or worsens swelling, rash, or fever develops

🤰 If Pregnant or Breast-Feeding 10 words ▾

If pregnant or breast-feeding, ask a health professional before use.

📄 Keep Out of Reach of Children 21 words ▾

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

📄 Questions or Comments 3 words ▾

Questions? 1-866-MUCINEX (1-866-682-4639)

📄 Package Label / Principal Display Panel 20 words ▾

PRINCIPAL DISPLAY PANEL - 2.4 mg Pouch Bag NDC 72854-261-20 Honey and Echinacea Front Label Honey and Echinacea Back Label

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for MUCINEX INSTASOOTHE SORE THROAT PLUS SOOTHING COMFORT (this brand).

Top reported reactions

Dizziness3
Anxiety2
Vision Blurred2
Blood Pressure Increased1
Bowel Movement Irregularity1
Brain Fog1
Diarrhoea1

Age at onset

Elderly1

Reporter sex

10 reports
Male · 25%
Female · 75%

Serious outcomes

Disabling2
Hospitalization1
Reports over time (by year) — tap or hover for the count & year
2021 2022 2024 2026 4 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
← 72854-0243-10 · Reckitt 72854-0262-20 · Reckitt →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.